Study on the Evaluation of Lung Cancer Patients from the Three Aspects of Emotion

Table 3

EORTC-QLQ-LC13 evaluation of the QoL of patients with lung cancer ().

QLQ-LC13	EORTC phase III-IV reference value (n = 1313)	Pre-chemotherapy score (n = 219)	T value	Post-chemotherapy score (n = 212)	F value
Cough	38.4 ± 22.3	35.47 ± 23.14	−1.78	32.76 ± 23.54	0.92
Hemoptysis	7.7 ± 17	12.64 ± 13.54	3.70	14.33 ± 21.27	0.39
Difficulty breathing	21.5 ± 24.6	25.34 ± 21.37	−4.14	28.06 ± 25.08	1.26
Mouth pain	5.1 ± 14.9	11.00 ± 18.24	4.45	13.24 ± 22.39	1.69
Hard to swallow	6.8 ± 17.8	10.02 ± 20.35	2.20	15.33 ± 26.09	4.89
Peripheral neuralgia	8.9 ± 19.36	15.60 ± 23.11	4.10	21.00 ± 28.17	2.47
Hair loss	5.2 ± 19.17	1.15 ± 8.38	−6.89	37.50 ± 32.90	115.74
Chest pain	20.8 ± 26.6	25.94 ± 27.35	2.69	29.00 ± 30.50	0.72
Arm shoulder pain	22.4 ± 27.52	16.42 ± 24.42	−3.51	18.83 ± 27.27	1.76
Other pain	23.8 ± 13.4	18.06 ± 15.19	−3.45	20.67 ± 17.81	1.66